int-2 oncogene amplification and prognosis in node-negative breast carcinoma

International Journal of Cancer

Volumn 74, Issue 6, 1997, Pages 620-624

  Fioravanti, Laura ^a   Cappelletti, Vera ^a   Coradini, Danila ^a   Miodini, Patrizia ^a   Borsani, Giorgio ^a   Daidone, Maria Grazia ^a   Di Fronzo, Giovanni ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROSTAGLANDIN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS;

ANALYSIS OF VARIANCE; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTORS; GENE AMPLIFICATION; HUMANS; LYMPH NODES; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; RECEPTORS, ESTROGEN;

EID: 0031470541     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971219)74:6<620::AID-IJC11>3.0.CO;2-9     Document Type: Article

References (32)

1. ADNANE, J., GAUDRAY, P., DIONNE, C., CRUMLEY, G., SCHLESSINGER, J., JEANTEUR, P., BIRNBAUM, D. and THEILLET, C., bek and flg. two receptors to members of the FGF family, are amplified in a subset of human breast cancer. Oncogene, 6, 659-663 (1991).
2. ADNANE, J., GAUDRAY, P., SIMON, M.P., SIMONY-LAFONTAINE, J., JEANTEUR, P. and THEILLET, C., Proto-oncogene amplification and human breast tumor phenotype. Oncogene, 4, 1389-1395 (1989).
3. BAIRD, A. and KLAGSBRUN, M., The fibroblast growth factor family. Cancer Cells, 3, 239-243 (1991).
4. BERNHEIM, A. and BERGER, R., Chromosomal localization of the proto-oncogene c-ets. Nature (Lond.), 310, 581-583 (1984).
5. BORG, A., SIGURDSSON, H., CLARK, G.M., FERNÖ. M., FUQUA, S.A.W., OLSSON, H., KILLANDER, D. and MCGUIRE, W.L., Association of int-2/hst-1 co-amplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Brit. J. Cancer, 63, 136-142 (1991).
6. BRISON, O., Gene amplification and tumor progression. Biochim. biophys. Acta, 1155, 25-41 (1993).
7. CAPPELLETTI, V., PATRIARCA, C., GRANATA, G., CATTORETTI, G., CORADINI, D., DI FRONZO, G. and HORWITZ, K., Progesterone receptor determination in human breast tumors by immunocytochemical and biochemical techniques. Breast Cancer Res. Treat., 14, 217-225 (1989).
8. CASEY, G., SMITH, R., MCGILLIVRAY, D., PETERS, G. and DICKSON, C., Characterisation and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol. cell. Biol., 6, 502-510 (1986).
9. CHAMPEME, M.H., BIÉCHE, I., HACÉNE, K. and LIDEREAU, R., Oncogene amplification per se: an independent prognostic factor in human breast cancer. Mol. Carcinogenesis, 11, 189-191 (1994).
10. CHAMPEME, M.H., BIÉCHE, I., LIZARD, S. and LIDEREAU, R., 11q13 Amplification in local recurrence of human primary breast cancer. Genes Chromosomes Cancer, 12, 128-133 (1995).
11. COX, D.R., Regression models and tables (with discussion). J. roy. Statist. Soc. B., 34, 248-275 (1972).
12. DELEHEDDE, M., BOILLY, B. and HONDERMARCK, H., Differential responsiveness of human breast cancer cells to basic fibroblast growth factor: a cell kinetics study. Oncol. Res., 7, 399-405 (1995).
13. DI FRONZO, G., CORADINI, D., CAPPELLETTI, V., MIODINI, P., GRANATA, G., SCHWARTZ, M. and PANKO, W.B., Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels. Anticancer Res., 10, 1699-1706 (1990).
14. DICKSON, C., Role of the int-genes in murine mammary tumor development and implications for human breast cancer. Int. J. Cancer, 5, 51-54 (1990).
15. DICKSON, C. and PETERS, G., Potential oncogene product related to growth factors. Nature (Lond.), 326, 833 (1987).
16. FANTL, V., SMITH, R., BROOKES, S., DICKSON, C. and PETERS, G., Chromosome 11q13 abnormalities in human breast cancer. Cancer Surv., 18, 77-94 (1993).
17. HENRY, J.A., HENNESY, C., LEVETT, D.L., LENNARD, T.W.J., WESTLKY, B.R. and MAY, F.E.B., int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB-2 and c-myc. Int. J. Cancer, 53, 774-780 (1993).
18. KAPLAN, E.L. and MEIER, P., Nonparametric estimation from incomplete observations. J. Amer. Statist. Assoc., 53, 457-481 (1958).
19. KARLSEDER, J., ZEILLINGER, R., SCHNEEBERGER, C., CZERWENKA, K., SPEISER, P., KUBISTA, E., BIRNBAUM, D., GAUDRAY, P. and THEILLET, C., Patterns of DNA amplification at band q13 of chromosome 11 in human breast Cancer. Genes Chromosomes Cancer, 9, 42-48 (1994).
20. KLIJN, J.G., BERNS, E.M. and FOEKENS, J.A., Prognostic factors and response to therapy in breast cancer. Cancer Surv., 18, 165-197 (1993).
21. LISCIA, D.S., MERLO, G.R., GARRET, C., FRENCH, D., MARIANI-COSTANTINI, R. and CALLAHAN, R., Expression of int-2 mRNA in human tumours amplified at the int-2 locus. Oncogene, 4, 1219-1224 (1989).
22. LöNN, U., LöNN, S., NILSSON, B. and STENKVIST, B., Breast cancer: prognostic significance of c-erbB2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features. Breast Cancer Res. Treat., 29, 237-245 (1994).
23. MANSOUR, E.G., RAVDIN, P.M. and DRESSLER, L., Prognostic factors in early breast carcinoma. Cancer, 74, 381-400 (1994).
24. MCGUIRE, W.L. and CLARK, G.M., Prognostic factors and treatment decision in axillary-node negative breast cancer. N. Engl. J. Med., 326, 1756-1761 (1992).
25. MULLER, W.J., LEE, F.S., DICKSON, C., PETERS, G., PATTENGALE, P. and LEDER, P., The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J., 9, 907-913 (1990).
26. ORNITZ, D.M., CARDIFF, R.D., KUO, A. and LEDER, P., int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants. J. nat. Cancer Inst., 84, 887-892 (1992).
27. OTTESTAD, L., ANDERSEN, T.I., NESLAND, J.M., SKREDE, M., TVEIT, K., NUSTAD, K. and BORRESEN, A.L., Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinoma. Acta Oncol., 32, 289-294 (1993).
28. RUDLAND, P.S., FERNIG, D.G. and SMITH, J.A., Growth factors and their receptors in neoplastic mammary glands. Biomed. Pharmacother., 49, 389-399 (1995).
29. SAHIN, A.A. and SNEIGE, N., Pathologic assessment of prognostic factors in patients with operable breast cancer. Cancer Bull., 45, 495-499 (1993).
30. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual. (2nd ed.), Cold Spring Harbor Laboratory Press, NY (1989).
31. 3H-thymidine labelling index in breast cancer. Cell Proliferation, 24, 437-445 (1991).
32. SILVESTRINI, R., DAIDONE, M.G., LUISI, A., BORACCHI, P. MEZZETTI, M., DI FRONZO, G., ANDREOLA, S., SALVADORI, B. and VERONESI, U., Biologic and clinicopathologic factors as indicators of specific relapse types in node- negative breast cancer. J. clin. Oncol., 13, 697-704 (1995).